Stock Events

Stock Events

Keymed Biosciences (2162.HK) Q3 2025 Earnings

26AugConfirmed

Q1 2024

Q3 2024

Q1 2025

Q3 2025

-1.71

-1.25

-0.79

-0.33

Details

Expected EPS

N/A

Actual EPS

-0.32627278425

Surprise EPS

-0.33

Surprise Percent

+∞%

Description

Keymed Biosciences (2162.HK) has reported earnings of -0.32627278425 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.